Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	289.36M -1.0%
Revenue (ttm)	363.14M +0.1%
Net Income	23.50M -2.0%
EPS	0.17 -2.1%
Shares Out	141.84M
PE Ratio	12.32
Forward PE	n/a
Dividend	0.11 (5.45%)
Ex-Dividend Date	Jun 26, 2026

Volume	27,600
Open	2.020
Previous Close	2.020
Day's Range	2.010 - 2.040
52-Week Range	2.010 - 2.200
Beta	0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs in Malaysia, Singapore, Vietnam, Philippines, Cambodia, Myanmar, Brunei, Indonesia, Thailand, Africa, and internationally. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also m...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,361
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2025, KLSE:YSPSAH's revenue was 365.12 million, a decrease of -0.96% compared to the previous year's 368.66 million. Earnings were 25.03 million, a decrease of -6.21%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 1, 2026

Data Sources Report a data error